European Genetic Testing and Screening Services Market

NEW YORK, July 16, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

http://www.reportlinker.com/p0933305/European-Genetic-Testing-and-Screening-Services-Market.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Genomics

The objective of this study is to assess the market potential of current testing areas pertaining to the area of genetics such as diagnostic testing/screeening, relationship testing and predictive testing. Revenue forecast has been provided for 2010-2018 for each segment within the United Kingdom, Germany, France, Italy, Spain, Scandinavia and Benelux. Regulations pertaining to genetic testing in Western European countries have been discussed. A comprehensive list of 90 commercial service providers has been provided.

•Genetic testing and screening are the next big focus in the area of molecular diagnostics.•Advances in accuracy and steady market growth are opening a number of exciting new doors when it comes to understanding, predicting and eventually treating disease.•This market is expected to be driven by the increasing availability of tests covering a wide range of disease areas and expanding the pool of potential consumers.•Testing for genetic diseases has rapidly moved from the laboratory into medical practice and, in this process, issues of quality require adequate attention.•With health insurance plans offering coverage for certain tests, prenatal diagnosis and symptomatic testing will be seen contributing significantly towards the genetic testing and screening market.•There is an increased awareness about tests amidst the common mass. This is primarily due to widespread genetic counselling groups and the availability of direct-to-consumer (DTC) tests.•The majority of all firms offering gene analyses and services are privately held, while some are start-ups; those that are public have other well-established lines of business on which to lean.•There is a noticeable geographical disparity in availability of tests. Although there is no clear evidence that explains this, the plethora and variety of demand-side mechanisms are likely to play a role.•The European genetic testing and screening services market was valued at $xmillion in 2011, and it is expected to witness a compound annual growth rate (CAGR) of xper cent to reach $xmillion in 2018.•Fastest growth will be observed in the predictive testing segment. This is expected to witness a CAGR of xper cent.•The demand for diagnostic testing/screening will remain the same, and this segment is anticipated to experience a CAGR of xper cent.•Relationship testing is currently facing legal implications in several European Union nations. However, due to a diverse regulatory environment, this segment is expected to witness a CAGR of xper cent.•In Europe, genetic services are mainly paid by the public health care system, so society as a whole also struggles with the increasing costs of licence fees. On the other hand, competition and development in the field have diminished the costs of many tests.

Market Overview 10

European Regulations 23

Industry Challenges 28

Total Genetic Testing and Screening Services Market -

External Challenges: Drivers and Restraints 33

Forecasts and Trends 40

Predictive Testing Segment Breakdown 52

Relationship Testing Segment Breakdown 57

Diagnostic Testing/Screening Segment Breakdown 61

The United Kingdom Breakdown 65

Germany Breakdown 71

France Breakdown 76

Italy Breakdown 80

Spain Breakdown 85

Scandinavia Breakdown 89

Benelux Breakdown 94

National Initiatives on Rare Diseases 99

Commercial Genetic Testing and Service Centres 101

Strategic Conclusions and Recommendations 112

The Last Word (Conclusions and Implications) 118

Appendix 121

More  

Check our  

Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker